Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | 5'-nucleotidase | References | |
Bos taurus | Intestinal alkaline phosphatase | References | |
Homo sapiens | 5'-nucleotidase, ecto (CD73) | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Hypothetical protein | 0.0137 | 0.1496 | 0.5 |
Treponema pallidum | 5'-nucleotidase (ushA) | 0.0335 | 1 | 0.5 |
Echinococcus multilocularis | alkaline phosphatase | 0.0196 | 0.4053 | 0.5 |
Echinococcus multilocularis | intestinal type alkaline phosphatase 1 | 0.0196 | 0.4053 | 0.5 |
Schistosoma mansoni | alkaline phosphatase | 0.0196 | 0.4053 | 0.4053 |
Schistosoma mansoni | 23-cyclic-nucleotide 2-phosphodiesterase | 0.0334 | 0.9959 | 0.9959 |
Echinococcus multilocularis | alkaline phosphatase, intestinal, gene 2 | 0.0196 | 0.4053 | 0.5 |
Echinococcus multilocularis | intestinal type alkaline phosphatase | 0.0196 | 0.4053 | 0.5 |
Toxoplasma gondii | 5'-nucleotidase, C-terminal domain-containing protein | 0.0335 | 1 | 1 |
Echinococcus granulosus | intestinal type alkaline phosphatase 1 | 0.0196 | 0.4053 | 0.5 |
Echinococcus granulosus | alkaline phosphatase intestinal gene 2 | 0.0196 | 0.4053 | 0.5 |
Echinococcus granulosus | intestinal type alkaline phosphatase | 0.0196 | 0.4053 | 0.5 |
Schistosoma mansoni | alkaline phosphatase | 0.0196 | 0.4053 | 0.4053 |
Echinococcus granulosus | alkaline phosphatase | 0.0196 | 0.4053 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.377 uM | Inhibition of human Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
IC50 (binding) | = 2.29 uM | Inhibition of calf intestinal alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
IC50 (binding) | = 3.61 uM | Inhibition of rat Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
IC50 (binding) | = 77.8 uM | Inhibition of bovine tissue non-specific alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
Ki (binding) | = 0.018 uM | Inhibition of human Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
Ki (binding) | = 0.172 uM | Inhibition of rat Ecto-5'-nucleotidase transfected in COS7 cells preincubated for 10 mins followed by AMP addition measured after 10 mins | ChEMBL. | 27054295 |
Ki (binding) | = 0.978 uM | Inhibition of calf intestinal alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
Ki (binding) | = 33.21 uM | Inhibition of bovine tissue non-specific alkaline phosphatase preincubated for 3 to 5 mins followed by CDP-star substrate addition measured after 15 mins by luminescence assay | ChEMBL. | 27054295 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.